Baxter International Inc. (BAX) Guidance & Earnings Results
On 2026-07-30 Baxter International Inc. raised guidance: "FY26 reported sales growth 3-4% (from flat to 1%); FY26 organic sales growth 2-3% (from ~flat); FY26 adjusted EPS $1.95-$2.15 (from…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BAXBaxter International Inc.Follow BAX — free
—
Price chart with a free account
- Market cap
- 13.1B
- P/E TTM
- —
- Dividend yield
- 0.8%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 30 Jul 26 | Raised | FY26 reported sales growth 3-4% (from flat to 1%); FY26 organic sales growth 2-3% (from ~flat); FY26 adjusted EPS $1.95-$2.15 (from $1.85-$2.05) · full year |
| 30 Oct 25 | Raised | Full-year sales growth guidance raised to 4-5% reported (from prior); adjusted EPS $2.35-$2.40 · full year |
| 31 Jul 25 | — | FY25 reported sales growth 6-7% (operational 3-4%); adjusted EPS $2.42-2.52. Q3 reported sales growth 6-7% (operational 3-4%); adjusted EPS $0.58-0.62. · full year |
Baxter International Inc. — questions
- What guidance did Baxter International Inc. give?
- On 2026-07-30: "FY26 reported sales growth 3-4% (from flat to 1%); FY26 organic sales growth 2-3% (from ~flat); FY26 adjusted EPS $1.95-$2.15 (from $1.85-$2.05)"
- When does Baxter International Inc. report earnings?
- Baxter International Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from Baxter International Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.